Type 2 diabetes mellitus+2
RecruitingA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
- Disease:Type 2 diabetes mellitusObesity+1
- Substances:–
Croatia- Participants:18–64 years · 65+ years
- Sponsor:Novo Nordisk A/S
Rare diseases
Investigational molecules
Locations
Back to Croatia7 clinical trials in Pula, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Croatia
Croatia
Croatia
Croatia
Croatia
Croatia
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Multiple innovative trials focusing on non-small cell lung cancer treatments, particularly evaluating combination therapies and new approaches for metastatic cases.
Research aims to improve outcomes for patients who have progressed after standard treatments.
Clinical research examining new treatments for agitation in Alzheimer's dementia, testing innovative therapeutic approaches to manage behavioral symptoms.
Studies focus on enhancing patient care and reducing caregiver burden.
Groundbreaking research in early-stage breast cancer treatment, specifically targeting estrogen receptor-positive, HER2-negative cases with novel endocrine therapies.
Trials aim to improve treatment outcomes through targeted therapeutic strategies.
Important studies in cardiovascular disease prevention, evaluating new treatments for reducing major adverse cardiovascular events in high-risk patients.
Research focuses on innovative preventive approaches for atherosclerotic cardiovascular disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.